{"altmetric_id":4701060,"counts":{"readers":{"mendeley":25,"citeulike":0,"connotea":0},"total":{"posts_count":4},"news":{"unique_users_count":4,"unique_users":["reuters","bioportfolio","bio_medicine_org","biospace"],"posts_count":4}},"citation":{"altmetric_jid":"4f6fa4f53cf058f610002e47","authors":["Chandraiah Lagisetti","Lagisetti C","Palacios G","Goronga T","Freeman B","Caufield W","Webb TR"],"doi":"10.1021\/jm401370h","endpage":"10044","first_seen_on":"2015-10-29T13:16:48+00:00","funders":["nci"],"isbns":[],"issns":["0022-2623","1520-4804"],"issue":"24","journal":"Journal of Medicinal Chemistry","last_mentioned_on":1446076800,"links":["http:\/\/pubs.acs.org\/doi\/abs\/10.1021\/jm401370h"],"pmid":"24325474","pubdate":"2013-12-11T00:00:00+00:00","publisher_subjects":[{"name":"Medicinal And Biomolecular Chemistry","scheme":"era"},{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"},{"name":"Organic Chemistry","scheme":"era"}],"scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics","Biochemistry, Genetics and Molecular Biology"],"startpage":"10033","subjects":["chemistry"],"title":"Optimization of Antitumor Modulators of Pre-mRNA Splicing","type":"article","volume":"56","mendeley_url":"http:\/\/www.mendeley.com\/research\/optimization-antitumor-modulators-premrna-splicing"},"altmetric_score":{"score":28,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":28},"context_for_score":{"all":{"total_number_of_other_articles":6500718,"mean":6.0222432796255,"rank":215504,"this_scored_higher_than_pct":96,"this_scored_higher_than":6284139,"rank_type":"exact","sample_size":6500718,"percentile":96},"similar_age_3m":{"total_number_of_other_articles":206585,"mean":10.274665375828,"rank":13734,"this_scored_higher_than_pct":93,"this_scored_higher_than":192800,"rank_type":"exact","sample_size":206585,"percentile":93},"this_journal":{"total_number_of_other_articles":3480,"mean":3.9611842483472,"rank":48,"this_scored_higher_than_pct":98,"this_scored_higher_than":3432,"rank_type":"exact","sample_size":3480,"percentile":98},"similar_age_this_journal_3m":{"total_number_of_other_articles":62,"mean":6.7883934426229,"rank":4,"this_scored_higher_than_pct":93,"this_scored_higher_than":58,"rank_type":"exact","sample_size":62,"percentile":93}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":1,"Researcher":5,"Student  > Ph. D. Student":11,"Student  > Postgraduate":1,"Student  > Master":1,"Student  > Bachelor":5},"by_discipline":{"Neuroscience":2,"Chemistry":9,"Agricultural and Biological Sciences":10,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"mendeley":{"US":1}}},"posts":{"news":[{"title":"SRI Biosciences Researchers Part of Team Reporting New Cancer Therapy Strategy in Nature","url":"http:\/\/ct.moreover.com\/?a=23182602936&p=1pl&v=1&x=F7TvVU2K3cDpy26FkW_sVA","license":"public","citation_ids":[4464999,4701060,4278869],"posted_on":"2015-10-28T17:49:03+00:00","summary":"PR Newswire MENLO PARK, Calif., Oct. 28, 2015 MENLO PARK, Calif., Oct. 28, 2015 \/PRNewswire\/ -- Two researchers from SRI Biosciences, a division of SRI International, were members of a team reporting in the journal Nature about a new way to target\u2026","author":{"name":"Reuters","url":"http:\/\/www.reuters.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/008\/normal\/reuters.png?1369846897"}},{"title":"SRI Biosciences Researchers Part of Team Reporting New Cancer Therapy Strategy in Nature","url":"http:\/\/ct.moreover.com\/?a=23182878866&p=1pl&v=1&x=ssf_dz3ZL-Kt7FJ1L-JtHQ","license":"public","citation_ids":[4464999,4701060,4278869],"posted_on":"2015-10-28T14:06:16+00:00","summary":"MENLO PARK, Calif., Oct. 28, 2015 \/PRNewswire\/ -- Two researchers from SRI Biosciences, a division of SRI International, were members of a team reporting in the journal Nature about a new way to target the gene underlying nearly a third of cancers.","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}},{"title":"SRI Biosciences Researchers Part of Team Reporting New Cancer Therapy Strategy... (   MENLO PARK Calif.   Oct. 28 2015 \/P...)","url":"http:\/\/ct.moreover.com\/?a=23183292667&p=1pl&v=1&x=1gKLwb3fZ9_PVAEQEpT5OA","license":"public","citation_ids":[4464999,4701060,4278869],"posted_on":"2015-10-28T18:59:11+00:00","summary":"... MENLO PARK Calif. Oct. 28 2015 \/PRNewswir...The spliceosome is a complex assembly of hundreds of proteins and RNA...In the recent findings published in Nature a team of biologist...The team found that this drug modulated the spliceosome and\u2026","author":{"name":"Bio-Medicine.org","url":"http:\/\/www.bio-medicine.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/031\/normal\/Screen_Shot_2014-07-16_at_14.10.25.png?1405516355"}},{"title":"SRI International Biosciences Researchers Part Of Team Reporting New Cancer Therapy Strategy In Nature","url":"http:\/\/ct.moreover.com\/?a=23193363838&p=1pl&v=1&x=lObasfZtmCUPCmHlRRgabw","license":"public","citation_ids":[4464999,4701060,4278869],"posted_on":"2015-10-29T00:00:00+00:00","summary":"MENLO PARK, Calif., Oct. 28, 2015 \/PRNewswire\/ -- Two researchers from SRI Biosciences, a division of SRI International, were members of a team reporting in the journal Nature about a new way to target the gene underlying nearly a third of cancers.","author":{"name":"Biospace","url":"http:\/\/www.biospace.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/375\/normal\/biospace.png?1437140433"}}]}}